Literature DB >> 15132415

Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis.

Sheraz Yaqub1, Kevin G Moder, Martha Q Lacy.   

Abstract

Pulmonary hypertension is an extremely serious and potentially fatal disorder. Although pulmonary hypertension is a potential complication of connective tissue disease, it has been reported rarely in patients with dermatomyositis. Similarly, multiple myeloma is rare in patients with dermatomyositis. We describe a patient with severe pulmonary hypertension who also had features of dermatomyositis and monoclonal gammopathy. To our knowledge, this is the first reported case of a patient in whom all 3 disorders occurred concurrently. Even more striking is the fact that the patient responded to treatment with cyclophosphamide and prostacyclin. He is asymptomatic more than 5 years after treatment was discontinued.

Entities:  

Mesh:

Year:  2004        PMID: 15132415     DOI: 10.4065/79.5.687

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  An unusual case of pulmonary hypertension in a young male.

Authors:  Carlo Rostagno; Stefania Ciolli; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature.

Authors:  Wayne L Feyereisn; Eric R Fenstad; Robert B McCully; Martha Q Lacy
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

Review 4.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

5.  Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy.

Authors:  Kavish J Bhansing; Anton Vonk-Noordegraaf; Frank Pt Oosterveer; Piet Lcm van Riel; Madelon C Vonk
Journal:  RMD Open       Date:  2017-06-09

6.  Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study.

Authors:  Brian Schwartz; Morten Schou; Frederick L Ruberg; Dane Rucker; Jihoon Choi; Omar Siddiqi; Kevin Monahan; Lars Køber; Gunnar Gislason; Christian Torp-Pedersen; Charlotte Andersson
Journal:  JACC CardioOncol       Date:  2022-07-19

7.  Severe Pulmonary Hypertension Caused by Smoldering Plasma Cell Myeloma: An Autopsy Case of POEMS Syndrome.

Authors:  Katsuya Chinen; Yasunori Fujioka
Journal:  Case Rep Med       Date:  2012-11-29

8.  Pulmonary hypertension in parenchymal lung disease.

Authors:  Iraklis Tsangaris; Georgios Tsaknis; Anastasia Anthi; Stylianos E Orfanos
Journal:  Pulm Med       Date:  2012-10-10

Review 9.  Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.

Authors:  Sébastien Sanges; Cécile M Yelnik; Olivier Sitbon; Olivier Benveniste; Kuberaka Mariampillai; Mathilde Phillips-Houlbracq; Christophe Pison; Christophe Deligny; Jocelyn Inamo; Vincent Cottin; Luc Mouthon; David Launay; Marc Lambert; Pierre-Yves Hatron; Laurence Rottat; Marc Humbert; Eric Hachulla
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.